Contraceptive pills recalled

Twenty-eight lots of oral contraceptives have been recalled by manufacturer Pfizer because some blister packs may contain an inexact count of inert or active-ingredient tablets and the tablets may be out of sequence.

The recall includes 14 lots of Lo/Ovral®-28 (norgestrel and ethinyl estradiol) tablets and 14 lots of generic norgestrel and ethinyl estradiol tablets. As a result of this packaging error, the daily regimen for these oral contraceptives may be incorrect and could leave women without adequate contraception and at risk for unintended pregnancy, the FDA warned.

Consumers who have been using the affected product should begin using a non-hormonal form of contraception immediately, notify their physicians and return the product to the pharmacy. A list of affected lot numbers is online.